The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

3. Sustainability of treatment: A significant number of people discontinue the medication due to the cost or when their ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss according to a University of Illinois professor ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The latter has made little difference: the popularity of Ozempic and other GLP-1 ... weight loss with regular use. “A couple of years ago there was an article published in Nature about an ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...